52 research outputs found

    EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection

    Get PDF
    The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology and practical application of nuclear medicine. Its 16,000 members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine. In addition to publishing journals, newsletters, and books, the SNMMI also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new advances in the science of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985

    Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period

    Get PDF
    Hospitalization for acute heart failure (HF) is associated with a substantial morbidity burden and with associated healthcare costs and an increased mortality risk. However, few if any major medical innovations have been witnessed in this area in recent times. Levosimendan is a first-in-class calcium sensitizer and potassium channel opener indicated for the management of acute HF. Experience in several clinical studies has indicated that administration of intravenous levosimendan in intermittent cycles may reduce hospitalization and mortality rates in patients with advanced HF; however, none of those trials were designed or powered to give conclusive insights into that possibility. This paper describes the rationale and protocol of LeoDOR (levosimendan infusions for patients with advanced chronic heart failure), a randomized, double-blind, placebo-controlled, international, multicentre trial that will explore the efficacy and safety of intermittent levosimendan therapy, in addition to optimized standard therapy, in patients following hospitalization for acute HF. Salient features of LeoDOR include the use of two treatment regimens, in order to evaluate the effects of different schedules and doses of levosimendan during a 12 week treatment phase, and the use of a global rank primary endpoint, in which all patients are ranked across three hierarchical groups ranging from time to death or urgent heart transplantation or implantation of a ventricular assist device to time to rehospitalization and, lastly, time-averaged proportional change in N-terminal pro-brain natriuretic peptide. Secondary endpoints include changes in HF symptoms and functional status at 14 weeks

    Recensiones [Revista de Historia Económica Año V Otoño 1987 n. 3 pp. 601-647]

    Get PDF
    Françoise Dosse. L'histoire en miettes. Des «Annales» a la «nouvelle histoire» (Por Femando G. Jaén).-- Jerónimo López-Salazar Pérez. Estructuras agrarias y sociedad rural en La Mancha (siglos XVI-XVII) (Por Enrique Llopis).-- Agustín Guimera Ravina. Burguesía extranjera y comercio atlántico: la empresa comercial irlandesa en Canarias (1703-1771) (Por Pedro Pérez Herrero).-- JMiguel Molina Martínez.El Real Tribunal de Minería de Lima (1785-1821) (Por Kenneth J. Andrien).-- Bárbara A. Tenenbaum. México en la época de los agiotistas, 1821-1857 (Por Inmaculada Romero-Hombrebucno).-- Joan Boadas i Raset. Girona després de la Guerra de Successió. Riquesa urbana i estructura social al primer quart del segle XVIII (Por Enriqueta Camps).-- V. Pinilla Navarro. Teruel (1833-1868). Revolución burguesa y atraso económico (Por M. Teresa Pérez Picazo).-- Jordi Nadal y otros. Catalunya, la fabrica d'Espanya (Un siglo de industrialización catalana, 1833-1936) (Por Sebastián Coll Martín).-- J. SardáDexeus. Escritos (1948-1980) (Por Pablo Martín Aceña).-- Esperanza Frax. Puertos y comercio de cabotaje en España, 1857-1934 y El mercado interior y los principales puertos, 1857-1920 (Por A. Gómez Mendoza).-- Vicent Soler Marco. Guerra i expansió industrial: Pais Valencia (1914-1923) (Por Albert Carreras).-- Guillermo Cortázar. Alfonso XIII, hombrede negocios. Persistencia del Antiguo Régimen, modernización económica y crisis política, 1902-1931 (Por Gabriel Tortella).-- S. N. Broadberry The British Economy between the Wars. A Macroeconomic Survey (Por Francisco Comín)Publicad

    Consenso para la mejora de la atención integral de los pacientes con insuficiencia cardíaca aguda

    Get PDF
    El último consenso sobre insuficiencia cardíaca aguda de la Sociedad Española de Cardiología, la Sociedad Española de Medicina Interna y la Sociedad Española de Medicina de Urgencias y Emergencias se elaboró en 2015, por lo que era necesaria una actualización para revisar las diversas novedades relacionadas con la temática de insuficiencia cardíaca aguda que han ido apareciendo los últimos años. Entre ellas están la publicación de las nuevas guías europeas sobre insuficiencia cardíaca en el 2016, nuevos estudios sobre el manejo farmacológico de los pacientes durante la hospitalización y novedades sobre diversos aspectos relacionados con la insuficiencia cardíaca aguda, tales como el abordaje precoz, terapia intermitente, insuficiencia cardíaca avanzada y congestión refractaria. Por ello, este consenso se elaboró con la intención de actualizar todos los aspectos relacionados con la insuficiencia cardíaca aguda y proporcionar un documento que detallase de manera completa el diagnóstico, tratamiento y manejo de esta enfermedad. The latest acute heart failure consensus document from the Spanish Society of Cardiology, Spanish Society of Internal Medicine, and Spanish Society of Emergency Medicine was published in 2015, which made an update covering the main novelties regarding acute heart failure from the last few years necessary. These include publication of updated European guidelines on heart failure in 2016, new studies on the pharmacological treatment of patients during hospitalization, and other recent developments regarding acute heart failure such as early treatment, intermittent treatment, advanced heart failure, and refractory congestion. This consensus document was drafted with the aim of updating all aspects related to acute heart failure and to create a document that comprehensively describes the diagnosis, treatment, and management of this disease

    ¿Quo vadis REM?

    No full text

    Comentarios bibliográficos

    No full text
    corecore